retatrutide is a glp 3 GLP-3 RT (LY3437943) Peptide Retatrutide (GLP-3) – Y&P Labs
Description
Weight loss on tirzepatide varies significantly between individuals due to metabolic, lifestyle, and genetic factors
The disparity in coverage between the anti-diabetic and anti-obesity GLP-1s shows how payer behavior is driven by the perceived medical necessity of products by their intended use, not by the molecule itself
Explore how pricing strategies influence access to these high-demand diabetes and obesity drugs.
It's clocking to me that Lizzo is standing on business.
Develop robust real-world evidence and value-based contracts to support inclusion on formularies
